Literature DB >> 20513425

Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supply.

Andrew Y Choo1, Sang Gyun Kim, Matthew G Vander Heiden, Sarah J Mahoney, Hieu Vu, Sang-Oh Yoon, Lewis C Cantley, John Blenis.   

Abstract

The mTORC1-signaling pathway integrates environmental conditions into distinct signals for cell growth by balancing anabolic and catabolic processes. Accordingly, energetic stress inhibits mTORC1 signaling predominantly through AMPK-dependent activation of TSC1/2. Thus, TSC1/2-/- cells are hypersensitive to glucose deprivation, and this has been linked to increased p53 translation and activation of apoptosis. Herein, we show that mTORC1 inhibition during glucose deprivation prevented not only the execution of death, but also induction of energetic stress. mTORC1 inhibition during glucose deprivation decreased AMPK activation and allowed ATP to remain high, which was both necessary and sufficient for protection. This effect was not due to increased catabolic activities such as autophagy, but rather exclusively due to decreased anabolic processes, reducing energy consumption. Specifically, TSC1/2-/- cells become highly dependent on glutamate dehydrogenase-dependent glutamine metabolism via the TCA cycle for survival. Therefore, mTORC1 inhibition during energetic stress is primarily to balance metabolic demand with supply. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20513425      PMCID: PMC2896794          DOI: 10.1016/j.molcel.2010.05.007

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  33 in total

1.  Akt and Bcl-xL promote growth factor-independent survival through distinct effects on mitochondrial physiology.

Authors:  D R Plas; S Talapatra; A L Edinger; J C Rathmell; C B Thompson
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

2.  A hierarchy of ATP-consuming processes in mammalian cells.

Authors:  F Buttgereit; M D Brand
Journal:  Biochem J       Date:  1995-11-15       Impact factor: 3.857

3.  Growth factors can influence cell growth and survival through effects on glucose metabolism.

Authors:  M G Vander Heiden; D R Plas; J C Rathmell; C J Fox; M H Harris; C B Thompson
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

4.  Bcl-xL prevents cell death following growth factor withdrawal by facilitating mitochondrial ATP/ADP exchange.

Authors:  M G Vander Heiden; N S Chandel; P T Schumacker; C B Thompson
Journal:  Mol Cell       Date:  1999-02       Impact factor: 17.970

Review 5.  Branched-chain amino acids as a protein- and energy-source in liver cirrhosis.

Authors:  Hisataka Moriwaki; Yoshiyuki Miwa; Masahiro Tajika; Masahiko Kato; Hideki Fukushima; Makoto Shiraki
Journal:  Biochem Biophys Res Commun       Date:  2004-01-09       Impact factor: 3.575

6.  TSC2 mediates cellular energy response to control cell growth and survival.

Authors:  Ken Inoki; Tianqing Zhu; Kun-Liang Guan
Journal:  Cell       Date:  2003-11-26       Impact factor: 41.582

7.  The pathways of glutamate and glutamine oxidation by tumor cell mitochondria. Role of mitochondrial NAD(P)+-dependent malic enzyme.

Authors:  R W Moreadith; A L Lehninger
Journal:  J Biol Chem       Date:  1984-05-25       Impact factor: 5.157

8.  Actin polymerization and ATP hydrolysis.

Authors:  E D Korn; M F Carlier; D Pantaloni
Journal:  Science       Date:  1987-10-30       Impact factor: 47.728

Review 9.  Glutamine and cancer.

Authors:  W W Souba
Journal:  Ann Surg       Date:  1993-12       Impact factor: 12.969

10.  Coupling of active ion transport and aerobic respiratory rate in isolated renal tubules.

Authors:  R S Balaban; L J Mandel; S P Soltoff; J M Storey
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

View more
  155 in total

Review 1.  The structure and allosteric regulation of mammalian glutamate dehydrogenase.

Authors:  Ming Li; Changhong Li; Aron Allen; Charles A Stanley; Thomas J Smith
Journal:  Arch Biochem Biophys       Date:  2011-11-04       Impact factor: 4.013

2.  The AMPK stress response pathway mediates anoikis resistance through inhibition of mTOR and suppression of protein synthesis.

Authors:  T L Ng; G Leprivier; M D Robertson; C Chow; M J Martin; K R Laderoute; E Davicioni; T J Triche; P H B Sorensen
Journal:  Cell Death Differ       Date:  2011-09-23       Impact factor: 15.828

3.  Oncology's energetic pipeline.

Authors:  Ken Garber
Journal:  Nat Biotechnol       Date:  2010-09       Impact factor: 54.908

Review 4.  The structure and allosteric regulation of glutamate dehydrogenase.

Authors:  Ming Li; Changhong Li; Aron Allen; Charles A Stanley; Thomas J Smith
Journal:  Neurochem Int       Date:  2010-11-09       Impact factor: 3.921

Review 5.  Evolving Lessons on the Complex Role of AMPK in Normal Physiology and Cancer.

Authors:  Biplab Dasgupta; Rishi Raj Chhipa
Journal:  Trends Pharmacol Sci       Date:  2015-12-20       Impact factor: 14.819

Review 6.  Glutamine and cancer: cell biology, physiology, and clinical opportunities.

Authors:  Christopher T Hensley; Ajla T Wasti; Ralph J DeBerardinis
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

7.  Glutaminolysis and carcinogenesis of oral squamous cell carcinoma.

Authors:  Marcel Cetindis; Thorsten Biegner; Adelheid Munz; Peter Teriete; Siegmar Reinert; Martin Grimm
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-07       Impact factor: 2.503

8.  p62/SQSTM1 Cooperates with Hyperactive mTORC1 to Regulate Glutathione Production, Maintain Mitochondrial Integrity, and Promote Tumorigenesis.

Authors:  Hilaire C Lam; Christian V Baglini; Alicia Llorente Lope; Andrey A Parkhitko; Heng-Jia Liu; Nicola Alesi; Izabela A Malinowska; Darius Ebrahimi-Fakhari; Afshin Saffari; Jane J Yu; Ana Pereira; Damir Khabibullin; Barbara Ogorek; Julie Nijmeh; Taylor Kavanagh; Adam Handen; Stephen Y Chan; John M Asara; William M Oldham; Maria T Diaz-Meco; Jorge Moscat; Mustafa Sahin; Carmen Priolo; Elizabeth P Henske
Journal:  Cancer Res       Date:  2017-05-16       Impact factor: 12.701

Review 9.  Pancreatic Cancer Metabolism: Molecular Mechanisms and Clinical Applications.

Authors:  Abdel Nasser Hosein; Muhammad Shaalan Beg
Journal:  Curr Oncol Rep       Date:  2018-05-11       Impact factor: 5.075

10.  mTORC1-Driven Tumor Cells Are Highly Sensitive to Therapeutic Targeting by Antagonists of Oxidative Stress.

Authors:  Jing Li; Sejeong Shin; Yang Sun; Sang-Oh Yoon; Chenggang Li; Erik Zhang; Jane Yu; Jianming Zhang; John Blenis
Journal:  Cancer Res       Date:  2016-05-17       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.